Fusō Pharmaceutical Industry (4538) FY2027 Q1 Financial Summary

Section Heading

This Financial Summary is structured around the Overview of Operating Results and the Quarterly Financial Statements and Key Notes, summarizing the performance and financial position for the first quarter of the fiscal year ending March 2027. The trends in revenue and profit for the first quarter against the previous year are shown in a comparison table, but the PDF does not disclose numeric figures, so exact amounts are unknown. Figures for assets, liabilities, and net assets are provided in the attached balance sheet and notes, illustrating the soundness of the capital structure. Note that depreciation and other items are also included in the notes as additional information.

Section 2 Heading

Factors affecting the outlook and performance include trends in the pharmaceutical business, raw material price movements, exchange rate effects, and capital expenditure policy. The quarterly financial statements provide details on the factors behind changes in assets and liabilities, cash and deposits, receivables and payables breakdown, and fixed asset status, offering shareholders material information on financial soundness. Regarding future outlook, it may refer to comparisons with the full-year plan and potential revisions, but the document itself does not state specific figures.